Development of HSP90 inhibitors-SN38 conjugates for cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of HSP90 inhibitors-SN38 conjugates for cancer treatment

Published:2023-08 Issue: Volume:137 Page:106582
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Cao Yuting,Shen Qianqian,Ding Mengyuan,Chen Yi,Lu Wei,Zhu Shulei

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference32 articles.

1. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020;Cao;Chin. Med. J.,2021

2. Cancer statistics for African American/Black People 2022. CA;Giaquinto;Cancer J. Clin.,2022

3. Leading causes of death and high mortality rates in an HIV endemic setting (Kisumu county, Kenya, 2019);Waruru;PloS one,2022

4. Zheng, R., Zhang, S., Zeng, H., Wang, S., Sun, K., Chen, R., He, J. Cancer incidence and mortality in China, 2016. J. Nat. Cancer Cent., 2022.

5. Siegel, R. L., Miller, K. D., Fuchs, H. E., Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin., 2022.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural products-isoxazole hybrids: A review of developments in medicinal chemistry;Arabian Journal of Chemistry;2024-06

2. Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates;Cancers;2023-11-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP